Header cover image

German (DAX) Biotech Industry Analysis

UpdatedOct 03, 2023
DataAggregated Company Financials
Companies20
  • 7D-1.9%
  • 3M-7.2%
  • 1Y-9.1%
  • YTD-10.1%

Over the last 7 days, the Biotech industry has dropped 1.0%, driven by a pullback from MorphoSys of 11%. The industry has fallen 6.8% in the last year. As for the next few years, earnings are expected to grow by 65% per annum.

Industry Valuation and Performance

Has the German Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 03 Oct 2023€3.9b€971.6m-€197,588,171.009.7x-19.6x4x
Thu, 31 Aug 2023€4.0b€954.5m-€53,175,027.0019.1x-74.7x4.2x
Sat, 29 Jul 2023€4.1b€955.5m-€219,213,323.0029.2x-18.7x4.3x
Mon, 26 Jun 2023€4.0b€967.4m-€212,883,319.0027.9x-18.9x4.2x
Wed, 24 May 2023€4.1b€967.4m-€209,726,026.0035x-19.6x4.3x
Fri, 21 Apr 2023€3.6b€927.5m-€212,539,789.0013.6x-16.9x3.9x
Sun, 19 Mar 2023€3.3b€890.4m-€224,291,844.009.9x-14.9x3.8x
Tue, 14 Feb 2023€3.0b€612.2m-€74,748,337.0011x-40.6x5x
Thu, 12 Jan 2023€3.1b€611.9m-€53,407,435.0011.6x-57.6x5x
Sat, 10 Dec 2022€3.1b€611.9m-€53,407,435.0011.3x-57.4x5x
Mon, 07 Nov 2022€2.6b€624.9m-€39,165,157.008.1x-65.2x4.1x
Wed, 05 Oct 2022€2.6b€627.4m-€129,805,157.005.1x-19.7x4.1x
Fri, 02 Sep 2022€2.6b€605.7m-€150,021,513.005.7x-17.5x4.3x
Sun, 31 Jul 2022€3.5b€772.0m-€724,268,362.00n/a-4.8x4.5x
Tue, 28 Jun 2022€3.4b€768.8m-€724,082,241.00n/a-4.7x4.4x
Thu, 26 May 2022€3.3b€768.8m-€724,082,241.00n/a-4.6x4.3x
Sat, 23 Apr 2022€3.6b€807.7m-€693,827,813.00n/a-5.2x4.5x
Mon, 21 Mar 2022€3.6b€806.5m-€675,731,845.00n/a-5.3x4.4x
Wed, 16 Feb 2022€3.7b€789.6m-€311,283,353.00n/a-11.8x4.7x
Fri, 14 Jan 2022€3.9b€789.6m-€311,283,353.00n/a-12.6x5x
Sun, 12 Dec 2021€4.0b€789.6m-€311,690,565.00n/a-12.8x5.1x
Tue, 09 Nov 2021€4.4b€771.2m-€257,628,521.00n/a-17.2x5.7x
Thu, 07 Oct 2021€4.3b€768.9m-€232,876,055.00n/a-18.5x5.6x
Sat, 04 Sep 2021€4.4b€769.4m-€175,243,228.001.4x-24.9x5.7x
Mon, 02 Aug 2021€4.4b€769.4m-€175,243,228.001.3x-24.9x5.7x
Thu, 06 May 2021€5.3b€749.9m-€236,050,839.001.1x-22.6x7.1x
Sun, 07 Feb 2021€6.0b€930.9m-€76,599,954.2333.1x-79x6.5x
Sat, 31 Oct 2020€5.0b€857.2m-€136,640,199.0255.3x-36.9x5.9x
Price to Earnings Ratio

-43.4x


Total Market Cap: €5.9bTotal Earnings: -€136,640,199.02Total Revenue: €857.2mTotal Market Cap vs Earnings and Revenue0%0%0%
German Biotech Industry Price to Earnings3Y Average -29.8x202120222023
Current Industry PE
  • Investors are pessimistic on the German Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.1x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 4.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market-1.19%
Healthcare-1.57%
Biotech-1.92%
Biotech-1.92%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FYB Formycon€57.304.4%
+€38.5m
-20.6%PS13.4x
T9G Vidac Pharma Holding€0.4521.6%
+€4.1m
n/an/a
T5O bioXXmed€1.485.7%
+€411.0k
-20.4%PS621.6x
ECX1 Epigenomics€0.696.2%
+€170.7k
-50.4%PS6.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PA8

€4.15

Paion

7D

-9.4%

1Y

-50.6%

CNW

€0.025

co.don

7D

-33.2%

1Y

-88.8%

HPHA

€3.39

Heidelberg Pharma

7D

-1.2%

1Y

-22.8%

MOR

€24.91

MorphoSys

7D

-11.0%

1Y

19.7%

20B

€0.18

Biomark Diagnostics

7D

-17.4%

1Y

37.4%

MDG1

€1.74

Medigene

7D

-1.4%

1Y

-17.0%

ECX1

€0.69

Epigenomics

7D

6.2%

1Y

-50.4%

T5O

€1.48

bioXXmed

7D

5.7%

1Y

-20.4%

2INV

€7.00

2invest

7D

-1.4%

1Y

-24.4%